`
`Company Profile I About I SENJU Pharmaceutical
`
`SENJU Senju Pharmaceutical Co.,Ltd.
`
`About Senju
`
`Overseas Actlvities
`
`Products
`
`Research & Development
`
`News
`
`Home >+ About Senju >+ Colr4lany Profile
`Company Profile
`
`> Message
`
`> Management Policy
`
`> Company Profile
`
`> Milestones in Our
`History
`
`> Data And Statistics
`
`Total Certificate of Past Records
`
`Trade name
`
`Principal Office
`
`Date of Incorporation
`
`Amount of capital
`
`Matters related to officers
`
`> Our Initiatives for Society
`I Environment
`
`> Business Activities
`
`> Ethical Products for
`Medical Professionals
`
`> OTC medicines
`
`>Animal Science
`
`> Research Laboratories
`
`> Production
`
`Corporate Prolile
`
`.. Company broctwre js
`available in PDF. !PDF:8MB]
`
`2-5-S,Hirano-machi, Chuo-ku, Osaka
`Senju Pharmaceutical Co.,Ltd.
`Company, Corporation, others No.:1299-01-082721
`
`Senju Pharmaceutical Co.,Ltd.
`
`2-5-S,Hirano-machi, Chuo-ku, Osaka
`
`April 9, 1947
`
`\1,415,500,000
`
`Chairman of the Board
`President & CEO
`Executive Vice President & COO
`Managing Executive Officer
`Managing Executive Officer
`
`Shoji Yoshida
`Yukoh Yoshida
`Shuhei Yoshida
`Mitsuyoshi Azuma
`Takashi Masuda
`
`Copyrighl e Sanju Pharmaceutical Co ,Ltd All r•ghts reserved Senju Pharmaceutical Co., Ltd. 1$1#-hi!UU\i
`
`pagatop 0
`
`Privacy Policy Tarlll$ or Usa
`
`http:l/www .senju.coj ~engl ish/abouVoutl ine.htm I
`
`111
`
`PAGE 1 OF 1
`
`SENJU EXHIBIT 2195
`INNOPHARMA v SENJU
`IPR2015-00903